Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 21, 2017
[The use of tumor therapeutics in the perioperative period]V Luber, J Wagner, J F Lock, et al.
Anticancer Research|March 28, 2001
Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamideJ T Hartmann, L M Fels, A Franzke, et al.
Blood Cancer Journal|February 12, 2013
Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling moleculesE Leich, S Weißbach, H-U Klein, et al.
Leukemia|April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomesP Hari, M-V Mateos, R Abonour, et al.
Leukemia|May 16, 2008
Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myelomaT Stühmer, A Zöllinger, D Siegmund, et al.
Leukemia|December 27, 2016
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)J Krönke, F Kuchenbauer, M Kull, et al.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
Leukemia|December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaA Palumbo, S V Rajkumar, M A Dimopoulos, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Pageof 3